UK phase IV, observational study to assess quality of life in patients (pts) with pancreatic neuroendocrine tumours (pNETS) receiving treatment with everolimus: The “real-world” OBLIQUE study

J. Ramage, P. Punia, O. Faluyi, A. Frilling, T. Meyer, G. Kapur, J. Cave, J. Wadsley, S. Cummins, D. Farrugia, N. Starling, L. Wall, R. Saharan, J. W. Valle

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)vi143
JournalAnnals of Oncology
Publication statusPublished - 1 Oct 2016

Cite this